NEOG
Neogen Corporation
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$11.83
+1.63%Forward multiples
Based on analyst estimates
- P/E forward
- 58.18x
- P/E 2026E
- 37.82x
- P/E 2027E
- 28.60x
- P/E 2028E
- 25.49x
- P/S forward
- 2.98x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.23x
- Price / sales
- 2.96x
- Price / cash flow
- 31.01x
Enterprise value
- Enterprise value
- $3.2B
- EV / sales
- 3.66x
- EV / EBITDA
- 18.53x
- EV / EBIT
- -147.13x
- Market cap
- $2.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of May 1, 2026